TRAIL, Wnt, Sonic Hedgehog, TGFβ, and miRNA Signalings Are Potential Targets for Oral Cancer Therapy-Reference-Cited by-同舟云学术

TRAIL, Wnt, Sonic Hedgehog, TGFβ, and miRNA Signalings Are Potential Targets for Oral Cancer Therapy

Published:2017-07-14 Issue:7 Volume:18 Page:1523
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Farooqi Ammad,Shu Chih-Wen,Huang Hurng-Wern,Wang Hui-Ru,Chang Yung-Ting,Fayyaz Sundas,Yuan Shyng-Shiou,Tang Jen-Yang,Chang Hsueh-Wei

Funder

Ministry of Science and Technology, Taiwan

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/18/7/1523/pdf

Reference157 articles.

1. Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) Is an Inhibitor of Autoimmune Inflammation and Cell Cycle Progression

2. TRAIL in cancer therapy: present and future challenges

3. Depolarization Controls TRAIL-Sensitization and Tumor-Selective Killing of Cancer Cells: Crosstalk with ROS

4. Opposing roles of TGF-β and EGF in the regulation of TRAIL-induced apoptosis in human breast epithelial cells

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping the intricacies of GLI1 in hedgehog signaling: A combined bioinformatics and clinical analysis in Head & Neck cancer in Western India;Current Problems in Cancer;2024-12

2. Resveratrol nanoparticles induce apoptosis in oral cancer stem cells by disrupting the interaction between β-catenin and GLI-1 through p53-independent activation of p21;Medical Oncology;2024-06-04

3. Growth Suppression of Oral Squamous Cell Carcinoma Cells by Lactobacillus Acidophilus;International Dental Journal;2024-04

4. Epigenetic programing of cancer stemness by transcription factors-non-coding RNAs interactions;Seminars in Cancer Biology;2023-07

5. Aptamers as Smart Ligands for Targeted Drug Delivery in Cancer Therapy;Pharmaceutics;2022-11-22